Slide 1MDS: Classification and Advances in Therapy BTG2013 S. Varma PGIMER, Chandigarh India Slide 2 MDS Highly heterogeneous group of disorders ▫ Variable natural history…
Clinical perspectives in higher risk MDS and AML with del 5q Lionel Adès Lenalidomide Combined to AZA in Higher Risk MDS with Del 5q A Study by the Groupe Francophone…